Talwin and Medrol drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Talwin (pentazocine lactate) and Medrol (methylprednisolone). Common drug interactions include abdominal distension among females and anhedonia among males.

The phase IV clinical study analyzes what interactions people have when they take Talwin and Medrol. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Talwin?

Talwin has active ingredients of pentazocine lactate. It is often used in pain. eHealthMe is studying from 893 Talwin users. Check the latest studies of Talwin.

What is Medrol?

Medrol has active ingredients of methylprednisolone. It is often used in rheumatoid arthritis. eHealthMe is studying from 24,443 Medrol users. Check the latest studies of Medrol.



On Jul, 25, 2026

12 people who take Talwin and Medrol together, and have interactions are studied.

Talwin and Medrol drug interactions.

What are the common drug interactions of Talwin and Medrol, by gender? *:

female:

  1. Abdominal distension
  2. Abdominal pain
  3. Abdominal pain upper
  4. Alanine aminotransferase increased
  5. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  6. Arthrodesis
  7. Blepharospasm (any abnormal contraction or twitch of the eyelid)
  8. Blood acid phosphatase increased
  9. Blood albumin decreased
  10. Blood calcium decreased

male:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Aortic calcification (aortic calcification sign of heart valve disease)
  3. Back pain
  4. Balance disorder
  5. Blood cholesterol increased
  6. Blood glucose increased
  7. Blood potassium increased
  8. Blood triglycerides increased
  9. Bradycardia (abnormally slow heart action)
  10. Cardiac failure congestive

What are the common drug interactions of Talwin and Medrol, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Aseptic necrosis bone
  2. Bone cyst
  3. Arthralgia (joint pain)
  4. Chondromalacia (anterior knee pain due to irritation of the cartilage on the under surface of the kneecap)
  5. Difficulty in walking
  6. Osteoarthritis (a joint disease caused by cartilage loss in a joint)
  7. Osteochondrosis (a family of orthopaedic diseases of the joint that occur in children and adolescents)
  8. Osteonecrosis (death of bone)
  9. Radiculopathy (a set of conditions in which one or more nerves is affected and does not work properly)
  10. Bone disorder

40-49:

  1. Chondromalacia (anterior knee pain due to irritation of the cartilage on the under surface of the kneecap)
  2. Constipation
  3. Cushing's syndrome (obesity, a rounded face, increased fat)
  4. Cushingoid (obesity and weakening of the muscles)
  5. Difficulty in walking
  6. Drug hypersensitivity
  7. Dry mouth
  8. Dysphagia (a condition in which swallowing is difficult or painful)
  9. Dyspnoea (difficult or laboured respiration)
  10. Faecal impaction

50-59:

  1. Atrial flutter (an abnormal heart rhythm that occurs in the atria of the heart)
  2. Atrioventricular block complete (heart block complete)
  3. Back pain
  4. Balance disorder
  5. Blood cholesterol increased
  6. Blood glucose increased
  7. Blood potassium increased
  8. Blood triglycerides increased
  9. Bradycardia (abnormally slow heart action)
  10. Cardiac failure congestive

60+:

  1. Drug hypersensitivity
  2. Arthralgia (joint pain)

What are the existing conditions these people have? *

  1. Rickets (softening of bones): 1 person, 8.33%
  2. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 1 person, 8.33%
  3. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 8.33%
  4. Blood Pressure Abnormal: 1 person, 8.33%
  5. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 1 person, 8.33%
  6. Drowsiness: 1 person, 8.33%
  7. Dry Eyes (lack of adequate tears): 1 person, 8.33%
  8. Gait Disturbance: 1 person, 8.33%
  9. High Blood Pressure: 1 person, 8.33%
  10. Hypersensitivity: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Talwin and Medrol?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Talwin and Medrol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Talwin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Medrol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Talwin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Medrol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on pentazocine lactate and methylprednisolone (the active ingredients of Talwin and Medrol, respectively), and Talwin and Medrol (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: